CHICAGO (CNNMoney.com) -- Nexavar, an approved kidney cancer drug developed by Onyx Pharmaceuticals and Bayer AG, is also effective in prolonging the survival of liver cancer patients, according ...

"Based on these encouraging data, Bayer and Onyx are evaluating various strategies for Nexavar in breast cancer. Nexavar is already benefiting patients worldwide with liver cancer and kidney ...

As a result of this recommendation, Bayer and Onyx will stop the trial and allow all patients enrolled in this trial access to Nexavar. Given that there are limited approved systemic therapies for ...

Mar. 23 -- MONDAY, Nov. 19 (HealthDay News) -- The Bayer anticancer drug Nexavar (sorafenib) has been approved by the U.S. Food and Drug Administration to treat the most common form of liver ...

REUTERS/Ina Fassbender FRANKFURT (Reuters) - German drugmaker Bayer said a Phase III trial of cancer drug Nexavar in patients with advanced breast cancer did not meet its primary endpoint of ...

If it does, the German drugmaker will be able to offer its blockbuster Nexavar and newer Stivarga as a one-two punch against the tough disease. That would be a unique position for Bayer among ...

The ruling allows Cipla to make a generic version of Bayer's Nexavar cancer treatment. BNET noted in January that the case was controversial because Bayer and Bristol-Myers Squibb were attempting ...

Bayer AG and Onyx Pharmaceuticals Inc. said their cancer drug Nexavar failed to prolong life in patients with lung tumors when used as an initial treatment. Patients with advanced non-squamous non ...

Bayer and Amgen clocked another failed indication-expansion effort for the cancer drug Nexavar. The companies announced Friday the drug did not hit its Phase-III primary target of improving ...

Bayer AG and Onyx Pharmaceuticals Inc.'s Nexavar was granted accelerated U.S. review as a potential treatment for liver cancer, a new use for the drug. The priority review means the U.S. Food and ...

SAN FRANCISCO (MarketWatch) -- The Food and Drug Administration has approved Nexavar tablets for the treatment of patients with advanced renal cell carcinoma, or kidney cancer, said Bayer ...

CHICAGO (CNNMoney.com) -- Nexavar, an approved kidney cancer drug developed by Onyx Pharmaceuticals and Bayer AG, is also effective in prolonging the survival of liver cancer patients, according ...